A novel structural class of potent inhibitors of NF-κB activation: structure–activity relationships and biological effects of 6-aminoquinazoline derivatives
- 1 September 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (18) , 3869-3878
- https://doi.org/10.1016/s0968-0896(03)00438-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Signal transduction through NF-κBImmunology Today, 1998
- Regulation of Immune Responses by NF-κB/Rel Transcription FactorsThe Journal of Experimental Medicine, 1998
- Helicobacter pylori infection activates NF-kappa B in gastric epithelial cellsGastroenterology, 1997
- NF-κB activation in human knee-joint synovial tissue during the early stage of joint inflammationBiochemical Society Transactions, 1997
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- NF-κB: Ten Years AfterCell, 1996
- Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndromeCritical Care Medicine, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Chapter 28. Novel Inhibitors of the Proteasome and Their Therapeutic Use in InflammationPublished by Elsevier ,1996
- Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysisImmunity, 1995